Abstract:Background Acute myeloid leukemia (AML) measurable residual disease (MRD) evaluated by multiparametric flow cytometry (MFC) is a surrogate for progression‐free and overall survival in clinical trials and patient management. Due to the limited number of detection channels available in conventional flow cytometers, panels used for assessing AML MRD are typically split into multiple tubes. This cripples the simultaneous and correlated assessment of all myeloblast measurements. In response, we prototyped a single‐tube 27‐color MFC assay for the evaluation of AML MRD, incorporating all recommended markers. Methods Marrow aspirates from 22 patients were processed for analysis using full spectrum flow cytometry (FSFC). The signal resolution of each marker was compared between samples stained with single antibody vs. the fully stained panel. The analytical accuracy for quantifying hematopoietic cells between our established 8‐color assay and the new 27‐color method were compared. Variations within an operator and between separate operators were assessed to evaluate the assays reproducibility. The limited of blank (LOB), limit of detection (LOD), and lower limit of quantification (LLOQ) of the 27‐color method were empirically determined using limiting dilution experiments. The stability of antibody cocktails over a period of 120 hours was also studied using cryopreserved marrow cells. Results The stain indices for all antibodies were lower in the fully stained panel compared to cells stained with one antibody but clear separations between negative and positive signals were achieved for all antibodies. Our results demonstrated a high concordance between the established 8‐color method and the new 27‐color assay for enumerating myeloblasts and MRD interpretation within and between operators. The data further showed that the single‐tube 27‐color assay easily achieved the minimum required detection sensitivity of 0.1%. When antibodies were combined, however, expression intensity of some antigens deteriorated significantly when stored. Conclusion Our single‐tube 27‐color panel is a suitable, high sensitivity flow cytometric approach that can be used for AML MRD testing, which improves the correlation of aberrant antigens and detection of asynchronous differentiation patterns. Based on the stability study, we recommend the full panel be made prior to staining. This article is protected by copyright. All rights reserved.

[Application of Vital Dye CFDA-SE and SNARF-1 to Evaluate Mixed Lymphocyte Reaction].

A Novel Three-parameter Flow Cytometric Analysis for Cell Cycle

[Application of Vital Dye CFDA-SE to Study Lymphocytic Proliferation].

The next step in the analysis of lymphocyte proliferation

The next step in the analysis of lymphocyte proliferation (152.7)

Application of vital dye CFDA-SE in transplant immune research

Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing

Determination of the Proliferation of CFSE Labeled Human T Lymphocyte Subpopulations by Flow Cytometry

Effect of Activation of Stimulator Cells on Expression of CD69 by Responder T Cells in Mixed Lymphocyte Reaction

Application of the membrane-inserting dye PKH26 in proliferation of lymphocytes and their subsets

Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line

Combined application of CFSE labeling and flow cytometry on the detection of the proliferation of CD4~+/CD8~+ T cells simulated with monocytes Siglec-1

Development of a novel flow cytometry‐based approach for reticulocytes micronucleus test in rat peripheral blood

CFSE-Based Proliferative Assay for CD8+ T Lymphocytes

The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.

One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Research of Rat Small Intestinal Mesentery Lymphoid Tissue Stimulating Allograft Mixed Lymphocyte Reaction

Rapid Detection of Immunoglobulin Heavy Chain Gene Rearrangement by PCR and Melting Curve Analysis Using Combined FR2 and FR3 Primers

Development of a 27‐color Panel for the Detection of Measurable Residual Disease in Patients Diagnosed with Acute Myeloid Leukemia

CFDA-SE Combined with MACSiBeads™ Particles to Evaluate the Inhibitory Effect of Treg Cells in vitro